Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three sessions, experts believe the panic is unfounded, maintaining confidence in the sectors’ long-term outlook. Trump’s recent 25% tariffs on auto exports to the US, along with additional duties, have further affected market sentiment.
Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?
Kaynes has plunged 43.5% from its October peak, with Friday’s 12.5% drop marking the steepest single-day decline. Momentum indicators remain bearish, signaling a risk of
December 7, 2025